Cutting-edge distribution center to reinforce Medline's supply chain resilience in California NORTHF

New York, New York--(Newsfile Corp. - July 20, 2026) - Kaplan Fox & Kilsheimer LLP is investigating

New York, New York--(Newsfile Corp. - July 17, 2026) - Kaplan Fox & Kilsheimer LLP is investigating

NEW YORK, July 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

Medline (NASDAQ:MDLN) today announced that it signed a new Prime Vendor agreement with Allina Health

SAN FRANCISCO, July 7, 2026 /PRNewswire/ -- National shareholder rights firm Hagens Berman Sobol Sha

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

Securing new 1.6-plus million square feet of new space after fire, Medline leases two large distribu

Massive new medical supplies distribution space represents 45% expansion of Medline's customer-facin

On CNBC's “Mad Money Lightning Round,” Jim Cramer said he likes Medline Inc. (NASDAQ:MDLN), adding t

Jim Cramer says Medline is "probably" the best IPO of 2026 and expects AST SpaceMobile to be

SAN FRANCISCO, July 01, 2026 (GLOBE NEWSWIRE) -- National shareholder rights firm Hagens Berman Sobo

NORTHFIELD, Ill., July 01, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today an

NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

Medline Inc. is rated a buy, driven by robust sector macroeconomics, strong ROE, organic Q1 growth,

NEW YORK, June 25, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

BILLERICA, Mass.--(BUSINESS WIRE)--Access Vascular, Inc. (“AVI”), a medical device company specializ

Investors looking for stocks in the Medical - Products sector might want to consider either ICU Medi

NEW YORK, June 18, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

A fire destroyed a Medline Inc. (NASDAQ:MDLN) medical equipment warehouse in Tracy, California, on T

Medline (MDLN) faces near-term headwinds after a major CA warehouse fire. William Blair analysts bre

Baird analyst Eric Coldwell maintains Medline (NASDAQ:MDLN) with a Outperform and lowers the pric

https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/m

Barclays analyst Glen Santangelo maintains Medline (NASDAQ:MDLN) with a Overweight and lowers the

Medline (NASDAQ:MDLN) announced that Medline Canada has signed its first Prime Vendor agreement in t

Medline (NASDAQ:MDLN) today announced that it signed a new Prime Vendor agreement with Rural Medical

Medline Inc. (NASDAQ:MDLN) ("Medline") announced today that certain selling stockholders aff

BNP Paribas analyst Navann Ty maintains Medline (NASDAQ:MDLN) with a Neutral and lowers the price

Tigress Financial analyst Ivan Feinseth maintains Medline (NASDAQ:MDLN) with a Buy and raises the

Citigroup analyst Patrick Donnelly maintains Medline (NASDAQ:MDLN) with a Buy and lowers the pric

Bernstein analyst Lee Hambright maintains Medline (NASDAQ:MDLN) with a Outperform and lowers the

https://www.fda.gov/medical-devices/letters-health-care-providers/disruptions-availability-neurosurg

Medline (NASDAQ:MDLN) reported quarterly earnings of $0.33 per share which beat the analyst consensu

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219163

Medline (NASDAQ:MDLN) announced a strategic agreement to implement next-generation warehouse automat

U.S. stock futures lower, with Dow futures down 150 points. Fastenal shares dip 4% after meeting ear

FDA warns Medline over device quality lapses, citing CAPA failures, contamination risks, and unresol

Groundbreaking is first operational initiative as a publicly traded company on its continued traject

JP Morgan analyst Lisa Gill maintains Medline (NASDAQ:MDLN) with a Overweight and raises the pric

Tigress Financial analyst Ivan Feinseth maintains Medline (NASDAQ:MDLN) with a Buy and raises the